Biocept (FRA:B00) PB Ratio : 61.26 (As of Jun. 07, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biocept PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-07), Biocept's share price is €6.80. Biocept's Book Value per Share for the quarter that ended in Jun. 2023 was €0.11. Hence, Biocept's PB Ratio of today is 61.26.

The historical rank and industry rank for Biocept's PB Ratio or its related term are showing as below:

During the past 12 years, Biocept's highest PB Ratio was 62.79. The lowest was 0.13. And the median was 2.37.

FRA:B00's PB Ratio is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.07
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Biocept's average Book Value Per Share Growth Rate was -99.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -36.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -41.40% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Biocept was -30.30% per year. The lowest was -66.10% per year. And the median was -43.50% per year.

Back to Basics: PB Ratio

Biocept PB Ratio Historical Data

The historical data trend for Biocept's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocept PB Ratio Chart

Biocept Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

PB Ratio

Get a 7-Day Free Trial

1.21

0.90

2.60

1.56

0.88

Biocept Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
PB Ratio	Get a 7-Day Free Trial															0.50	0.56	0.88	2.33	61.26

Competitive Comparison of Biocept's PB Ratio

For the Diagnostics & Research subindustry, Biocept's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocept's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocept's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biocept's PB Ratio falls into.

Biocept PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biocept's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2023)
	=	6.80	/	0.111
	=	61.26

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Biocept (FRA:B00) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Biocept PB Ratio Related Terms

Thank you for viewing the detailed overview of Biocept's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocept (FRA:B00) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocept Inc (FRA:B00) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

BIOCQ:USA

Address

9955 Mesa Rim Road, San Diego, CA, USA, 92121

Website

https://www.biocept.com

Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.

Biocept (FRA:B00) Headlines

No Headlines